Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NV03 is a potent and selective antagonist of UHRF1 (Ubiquitin-like with PHD and RING finger domains 1)- H3K9me3 interaction by binding to UHRF1 tandem tudor domain, with a K d of 2.4 μM. NV03 is a possible application as anticancer therapeutics [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 379,000 |
50 mg | 約6-8 週間 | ¥ 493,500 |
100 mg | 約6-8 週間 | ¥ 799,000 |
説明 | NV03 is a potent and selective antagonist of UHRF1 (Ubiquitin-like with PHD and RING finger domains 1)- H3K9me3 interaction by binding to UHRF1 tandem tudor domain, with a K d of 2.4 μM. NV03 is a possible application as anticancer therapeutics [1]. |
分子量 | 389.52 |
分子式 | C19H27N5O2S |
CAS No. | 2448341-58-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NV03 2448341-58-8 Others NV 03 NV-03 Inhibitor inhibitor inhibit